The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to bolster pipelines.

Source: [CNBC](https://www.cnbc.com/2026/06/09/gsk-in-talks-to-acquire-nuvalent-for-more-than-9-billion.html)

Sponsored